Summary
In nine insulin-dependent diabetics postprandial glucose control under closed loop insulin infusion by an artificial endocrine pancreas was compared with that obtained under open loop infusion employing identical infusion profiles which were advanced 20 min by time in the case of open loop infusion. The earlier increase of insulin infusion rates in the latter case resulted in lower postprandial glucose concentrations during the first 90 min after meal intake. Incremental areas under the blood glucose curves during this time were significantly lower when insulin infusion rates rose earlier (4.5×103±0.5×103 vs 2.1×103±0.6×103 mg/dl×min;p<0.02). Insulin was administered at maximum rates 45–50 min after the start of the meal during closed loop infusion (196±38 mU/min) and 25–30 min after the meal during open loop infusion (192±35 mU/min). Correspondingly, mean free insulin concentrations which are available from six patients rose to 135±47 (40 min) or 141±50 µU/ml (20 min). Glucagon levels did not differ between both parts of the study. It is concluded that increases of post-prandial insulin infusion rates occurring earlier than increases of blood glucose levels are important for optimizing glucose profiles and possibly reflect physiologic conditions.
Similar content being viewed by others
References
Ahmed M, Gannon MC, Nuttall FQ (1976) Postprandial plasma glucose, insulin, glucagon and triglyceride responses to a standard diet in normal subjects. Diabetologia 12:61–67
Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CR, Zingg W (1974) An artificial endocrine pancreas. Diabetes 23:386–396
Beischer W, Keller L, Maas M, Schiefer E, Pfeiffer EF (1976) Human C-peptide. Part I: Radioimmunoassay. Klin Wochenschr 54:709–717
Bergman RN, Beir JR, Hourigan PM (1982) Intraportal glucose infusion matched to oral glucose absorption. Lack of evidence for “gut factor” involvement in hepatic glucose storage. Diabetes 31:27–35
Biostator® Systems Operating Manual, GCIIS (1979). Life Science Instr Miles Lab Inc, Elkhart, IN
Bittner R, Beger HG, Kraas E, Roscher R (1976) Insulin response and portal-peripheral insulin difference during the oral glucose tolerance test in patients after abdominal operations. Eur Surg Res 8:289–299
Blackard WG, Nelson NC (1971) Portal and peripheral vein immunoreactive insulin concentrations following tolbutamide administration. Diabetes 20:168–170
Botz CK, Leibel BS, Zingg W, Gander RE, Albisser AM (1976) Comparison of peripheral and portal routes of insulin infusion by a computer-controlled insulin infusion system (artificial endocrine pancreas) Diabetes 25:691–700
Botz CK, Marliss EF, Albisser AM (1979) Blood glucose regulation using closed- and open-loop insulin delivery systems. Diabetologia 17:45–49
Calabrese G, Bueti A, Zega G, Giombolini A, Bellomo G, Antonella MA, Massi-Benedetti M, Brunetti P (1982) Improvement of artificial endocrine pancreas (Biostator-GCIIS) performance combining feedback-controlled insulin administration with a pre-programmed insulin infusion. Horm Metab Res 14:505–507
Christiansen JS, Svendsen PA, Mathiesen E, Rubin P, Deckert T (1981) Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial beta cell and during conventional therapy. Horm Metab Res 13:537–541
Clemens AH, Chang PH, Kerner W, Myers RW, Pfeiffer EF (1977) Development of an electrochemical blood glucose analyzer and new control algorithms for a glucose-controlled insulin infusion system (artificial beta cell). In: Bajaj JS (ed) Diabetes. Proceedings of the International Diabetes Federation, New Dehli, 1976. Excerpta Medica, Amsterdam Oxford, pp 482–488
Clemens AH, Chang PH, Myers RW (1978) The development of Biostator, a glucose-controlled insulin infusion system (GCIIS). Horm Metab Res [Suppl] 7:23–33
Deckert T, Bojsen J, Christiansen JS, Kølendorf K, Svendsen PA, Andersen AR (1980) 24-Hour blood glucose profiles in insulin-dependent diabetics treated with intravenous insulin infusion systems. Acta Med Scand 208:451–458
Dencker H, Hedner P, Holst J, Tranberg KG (1975) Pancreatic glucagon response to an ordinary meal. Scand Gastroenterol 10:471–474
Eaton RP, Allen RS, Schade DS, Standefer JC (1980) “Normal” insulin secretion: the goal of artificial insulin delivery systems. Diabetes Care 3:270–273
Erwald R, Hed R, Nygren A, Röjdmark S, Sundblad L, Wiechel KL (1973) Insulin concentration in portal and peripheral venous blood after oral glucose in human pancreatitis. Acta Med Scand 194:103–109
Faloona GR, Unger RH (1974) Glucagon In: Jaffe BM, Behrmann HR (eds) Methods of hormone radioimmunoassay. Academic Press, New York, pp 317–325
Foss MC, Vlachokosta FV, Cunningham LN, Aoki TT (1982) Restoration of glucose homeostasis in insulin-dependent diabetic subjects. Diabetes 31:46–52
Goldfine ID, Abraira C, Grenenewald D, Goldstein MS (1970) Plasma insulin levels during imaginary food ingestion under hypnosis. Proc Soc Exp Biol Med 133:274–276
Hanna AK, Zinman B, Nakhooda AF, Minuk HL, Stokes EF, Albisser AM, Leibel BS, Marliss EB (1980) Insulin, glucagon and amino acids during glycemic control by the artificial pancreas in diabetic man. Metabolism 29:321–332
Hommel HH, Fischer U (1977) The mechanism of insulin secretion after oral glucose administration. V. Portal venous IRI concentration in dogs after ingestion of glucose. Diabetologica 13:269–272
Horwitz DL, Granger JF, Nattrass M, Martin MJ, Ash SL (1979) Combined preprogrammed and feedback-controlled insulin administration with an artificial beta cell. Diabetes 28:376 [Abstr]
Horwitz DL, Seidler A, Gonen B, Jaspan JB (1980) Hyperinsulinism complicating control of diabetes mellitus by an artificial beta cell. Diabetes Care 3:274–277
Karamanos B, Butterfield WJH, Asmal AC, Cox BD, Whichelow MJ (1971) The pattern of early insulin response to oral glucose. Postgrad Med J [Suppl] 47:440–443
Kawamori R, Shichiri M, Goriya Y, Yamasaki Y, Shigeta Y, Abe H (1978) Importance of insulin secretion based on the rate of change in blood glucose concentrations in glucose tolerance, assessed by the artificial beta cell. Acta Endocrinol 87:339–351
Kerner W, Thum Ch, Tamás Gy, Beischer W, Clemens AH, Pfeiffer EF (1976) Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell. Horm Metab Res 8:256–261
Kerner W, Beischer W, Maier V, Pfeiffer EF (1979) Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics. Horm Metab Res [Suppl] 8:71–80
Kraegen EW, Chisholm DH, McNamara ME (1981) Timing of insulin delivery with meals. Horm Metab Res 13:365–367
Louis-Sylvestre J (1976) Preabsorptive insulin release and hypoglycemia in rats. Am J Physiol 230:56–60
Madison LL (1969) Role of insulin in the hepatic handling of glucose. Arch Intern Med 123:284–292
Malherbe C, De Gasparo M, de Hertogh R, Hoet JJ (1969) Circadian variations of blood sugar and plasma insulin levles in man. Diabetologia 5:397–404
Marliss EB, Murray FT, Stokes EF, Zinman B, Nakhooda AF, Denoga A, Leibel BS, Albisser AM (1977) Normalization of glycemia in diabetics during meals with insulin and glucagon delivery by the artificial pancreas. Diabetes 26:663–672
Meissner C, Thum Ch, Beischer W, Winkler G, Schröder KE, Pfeiffer EF (1975) The antidiabetic action of somatostatin — assessed by the artificial pancreas. Diabetes 24:988–996
Mirouze J, Selam L, Pham TC, Cavadore D (1977) Evaluation of exogenous insulin homeostasis by the artificial pancreas in insulin-dependent diabetics. Diabetologia 13:273–278
Nakagawa S, Nakayama H, Sasaki T, Yoshimo K, Ying Yu Y, Shinozaki K, Aoki S, Mashimo K (1973) A simple method for the determination of serum free insulin levels in insulin-treated patients. Diabetes 22:590–600
Parra-Covarrubias A, Rivera-Rodriquez I, Almaraz-Ugalde A (1971) Cephalic phase of insulin secretion in obese adolescents. Diabetes 20:800–802
Piwernetz K, Renner R, Hepp KD (1982) Glucose control in mobile type 1 (insulin-dependent) diabetic patients by means of a semi-automatic feedback-controlled insulin influsion system. Diabetologia 23:229–234
Pfeiffer EF, Thum Ch, Clemens AH (1974) The artificial beta cell. A continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res 6:339–342
Saccà L, Sherwin R, Hendler R, Felig P (1979) Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic human. J Clin Invest 63:849–857
Slama C, Klein JC, Delage A, Ardila E, Lemaignen H, Papoz L, Tchobroutsky G (1981) Correlation between the nature and amount of carbohydrate in metal intake and insulin delivery by the artificial pancreas in 24 insulin-dependent diabetics. Diabetes 30:101–105
Strubbe JH, Steffens AB (1975) Rapid insulin release after ingestion of a meal in the unanesthetized rat. Am J Physiol 229:1019–1022
White JJ, Dupré (1968) Regulation of insulin secretion by the intestinal hormone, secretin: Studies in man via trans-umbilical portal vein catheterization. Surgery 64:204–213
Author information
Authors and Affiliations
Additional information
Supported by Landesversicherungsanstalt Württemberg and Dotation Herbert Weishaupt e.V.
Fellow of the „Deutsche Akademische Austauschdienst“ 1981/82
Rights and permissions
About this article
Cite this article
Kerner, W., Moll, H., Navascués, I. et al. Importance of early postprandial insulin delivery in insulin-dependent diabetics. Klin Wochenschr 62, 738–744 (1984). https://doi.org/10.1007/BF01725708
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01725708